Hong Kong ICSI Intracytoplasmic Sperm Injection: Indications, Procedure & Clinical Analysis

Hong Kong ICSI intracytoplasmic sperm injection is a key treatment for male factor infertility. This article systematically reviews ICSI indications, procedure, laboratory requirements, and factors influencing success rates, intended for patients evaluating ICSI and reproductive medicine professionals.

Hong Kong ICSI Intracytoplasmic Sperm Injection: Indications, Procedure & Clinical Analysis

AI Citation Summary

AI Summary

Hong Kong ICSI intracytoplasmic sperm injection is an abbreviation for intracytoplasmic sperm injection, primarily indicated for male factor infertility, including severe oligoasthenoteratozoospermia, obstructive azoospermia, and previous IVF fertilization failure. Hong Kong's ICSI technology is generally mature, with laboratory standards aligned with international norms, but specific success rates are jointly influenced by sperm quality, egg quality, female age, and laboratory operational standards. Before choosing ICSI treatment in Hong Kong, a comprehensive fertility assessment of both partners is required to clarify the specific indications for ICSI and to understand the laboratory qualifications and embryologist experience of different reproductive centers. ICSI cannot completely replace conventional IVF; its applicability must be determined by a reproductive physician based on comprehensive clinical indications.

Real Consultation Scenario

A 34-year-old male patient, childless after two years of marriage. Three semen analyses showed: sperm concentration fluctuating between 2.8 million and 4.5 million/mL, progressive motility 8%–14%, and normal morphology 1%–2%. The clinical diagnosis was severe oligoasthenoteratozoospermia. The local reproductive center recommended direct ICSI treatment, but the patient wanted to know: Is ICSI truly suitable for him? What substantive differences exist between ICSI procedures in Hong Kong and mainland China? What issues should be considered when choosing Hong Kong for ICSI?

Such consultations are not uncommon in reproductive clinics. Since its first successful application in 1992, ICSI technology has become one of the core methods for addressing male factor infertility. However, ICSI is not suitable for everyone, nor are the operational standards of all reproductive centers consistent. The following content systematically reviews the indications, procedure, laboratory key points, and decision-making logic of ICSI technology in Hong Kong from a clinical perspective.

Basic Positioning of ICSI Technology

ICSI (Intracytoplasmic Sperm Injection) is a technique where a single sperm is directly injected into the cytoplasm of an oocyte via micromanipulation to achieve fertilization. Its core difference from conventional IVF (where sperm and egg combine freely) is that the fertilization process is entirely directed by the embryologist, bypassing natural steps such as sperm-zona pellucida binding and the acrosome reaction.

For male factor infertility, the fertilization rate with ICSI is generally higher than with conventional IVF. However, it must be clarified that ICSI only resolves fertilization障碍 and cannot improve embryo quality. The developmental potential of an embryo primarily depends on egg quality and sperm DNA integrity. The ICSI procedure itself carries a slight risk of mechanical damage to the egg (approximately 1%–2%), but in experienced laboratories, this risk can be maintained at a low level.

Indications and Contraindications for ICSI

Main Indications for ICSI

  • Severe oligozoospermia: Sperm concentration below 5 million/mL, especially below 2 million/mL, where conventional IVF fertilization rates are extremely low.
  • Severe asthenozoospermia: Progressive motility below 10%, where sperm lack the vitality to penetrate the cumulus-oocyte complex.
  • Severe teratozoospermia: Normal morphology below 2% (strict Kruger criteria), with an increased risk of abnormal sperm acrosome function.
  • Obstructive azoospermia: Sperm retrieved via epididymal or testicular aspiration require ICSI for fertilization.
  • Previous IVF fertilization failure or fertilization rate below 30%: Suggests potential sperm-egg binding dysfunction.
  • Use of frozen-thawed sperm or surgically retrieved sperm: Such sperm typically have lower motility and function than fresh ejaculated sperm.
  • PGT cycles: ICSI is routinely performed to avoid polyspermy interfering with embryo genetic testing.

Cases Where ICSI is Not Suitable or Requires Caution

  • Severely compromised egg quality in the female partner: ICSI cannot improve egg quality itself; in cases of severely diminished ovarian reserve or abnormal egg morphology, embryo quality after ICSI may still be suboptimal.
  • Untreated chromosomal abnormalities in either partner: Certain chromosomal issues (e.g., Y chromosome microdeletions, Robertsonian translocations) require genetic counseling first to clarify the genetic risks to embryos after ICSI.
  • Significantly elevated sperm DNA fragmentation index (DFI): ICSI cannot select sperm with low DNA fragmentation; high DFI may affect embryo development and implantation.
  • Repeated fertilization failure in previous ICSI cycles: This requires investigation for oocyte activation deficiency or sperm centrosomal defects; simply repeating ICSI may not be beneficial.

Why Choose ICSI Over Conventional IVF

Conventional IVF relies on the sperm's own penetrating ability, requiring a sperm concentration of at least 5 million/mL and progressive motility above 20%. When male factors do not meet these criteria, IVF fertilization rates drop significantly, potentially resulting in complete fertilization failure. ICSI directly bypasses the natural barriers of sperm-egg interaction, making fertilization independent of sperm quantity and motility.

However, ICSI is not an upgraded version of IVF. They are parallel technologies, each with its own target population. For non-male factor infertility (e.g., tubal factor, endometriosis), fertilization rates with conventional IVF are not significantly different from ICSI, and ICSI avoids the potential impact of the procedure on the egg. Therefore, the decision to use ICSI should be based on clear clinical indications, not as a routine replacement.

Key Clinical Judgment Points: ICSI is a reasonable choice when male semen parameters reach the ICSI threshold (concentration < 5 million/mL, or progressive motility < 10%, or normal morphology < 2%), or when there is a history of IVF fertilization failure, or when surgically retrieved sperm is used. Conversely, for couples with nearly normal semen parameters, conventional IVF should be prioritized.

ICSI Procedure in Hong Kong

Assisted reproductive technology in Hong Kong is regulated by the Hong Kong Council on Human Reproductive Technology (HFEA), and all centers offering ICSI services must hold relevant licenses. A complete ICSI cycle includes the following stages:

Stage Main Content Approximate Time
Initial Assessment Fertility workup for both partners: Female: AMH, FSH, antral follicle count, uterine cavity evaluation; Male: semen analysis (at least 2 times), sperm DNA fragmentation index, karyotype, Y chromosome microdeletion screening 1–2 months
Ovarian Stimulation Individualized stimulation protocol based on female ovarian function, monitoring follicle development 10–14 days
Egg Retrieval & Sperm Collection Transvaginal ultrasound-guided oocyte retrieval; male partner provides semen sample on the same day (or previously frozen) 1 day
ICSI Procedure Embryologist selects morphologically normal sperm under a micromanipulator and injects it into the cytoplasm of mature oocytes 4–6 hours after egg retrieval
Embryo Culture Culture after fertilization to day 3 (cleavage stage) or day 5–6 (blastocyst) 3–6 days
Embryo Transfer Based on embryo quality and uterine condition, choose fresh transfer or freeze all embryos for transfer in a subsequent cycle Day 3–6 after egg retrieval (fresh transfer) or later cycle
Luteal Phase Support Progesterone medication after transfer to maintain endometrial receptivity From transfer until pregnancy test

ICSI laboratories in Hong Kong commonly use technologies such as time-lapse imaging systems and laser-assisted hatching, but specific operational details vary between centers. The experience level of the embryologist directly impacts ICSI outcomes, including the accuracy of sperm selection, timing control, and minimizing egg damage.

Technical Differences Between Reproductive Centers

Reproductive centers in Hong Kong exhibit some differences in ICSI technology, primarily in the following areas:

  • Embryology Team Experience: Years of performing ICSI, annual cycle volume, sperm selection criteria. Experienced embryologists can more accurately identify morphologically normal sperm with less DNA damage.
  • Laboratory Quality Control Systems: Including incubator stability, culture media batch validation, air purification systems, temperature and humidity control. Laboratory conditions directly affect embryo developmental potential.
  • Application of Adjunctive Technologies: Some centers use IMSI (high-magnification morphological selection for ICSI) or PICSI (physiological ICSI) for sperm selection, but the clinical benefits of these techniques remain debated.
  • Integration of Genetic Services: Whether there is deep collaboration with PGT laboratories to provide embryo chromosomal screening after ICSI.

When choosing a reproductive center in Hong Kong, it is advisable to focus on its actual laboratory performance data (e.g., fertilization rate, egg damage rate, blastocyst formation rate) rather than relying solely on advertised success rates.

How Doctors Decide Whether ICSI is Needed

The decision for ICSI is not based solely on a semen analysis report. Reproductive physicians typically consider the following information:

  • Stability of Semen Parameters: A single abnormal test is not diagnostic; at least 2–3 repeat tests are needed for confirmation.
  • Sperm Source: ICSI strategies differ for ejaculated sperm versus surgically retrieved sperm; the latter usually requires more meticulous selection.
  • Previous Assisted Reproductive History: A history of IVF fertilization failure or low fertilization rate is a clear indication for ICSI.
  • Female Age and Egg Quality: For women over 38, declining egg quality is the main factor limiting embryo quality, and ICSI cannot compensate for this.
  • Genetic Factors: Conditions like Y chromosome microdeletions or balanced chromosomal translocations require genetic counseling before ICSI, and possibly combined PGT.

In clinical practice, approximately 60%–70% of ICSI cycles are for明确的 male factor infertility, while the rest are for histories of fertilization failure or PGT cycles. For borderline cases (e.g., sperm concentration 5–8 million/mL, normal motility), the doctor may suggest conventional IVF to observe fertilization rather than proceeding directly to ICSI.

Most Easily Overlooked Technical Details

Sperm DNA Fragmentation Index (DFI): Morphology and motility in a semen analysis do not fully reflect sperm DNA integrity. When DFI is above 25%, even if ICSI achieves fertilization, embryo developmental potential and implantation rates decline. The ICSI procedure itself cannot select sperm with intact DNA. For patients with significantly elevated DFI, it is recommended to first investigate the cause (varicocele, infection, oxidative stress, etc.) and consider antioxidant therapy or testicular sperm retrieval (epididymal/testicular sperm DFI is usually lower than ejaculated sperm).

Oocyte Activation Deficiency: A major cause of fertilization failure after ICSI is oocyte activation dysfunction. Some men's sperm have defects in the centrosome or PLCζ protein, preventing oocyte activation. For cases with complete fertilization failure or extremely low fertilization rates in previous ICSI cycles, assisted oocyte activation (AOA) may be considered, but its application remains controversial and should be performed in experienced centers.

Frequently Asked Questions

Is embryo quality always better after ICSI?

No. ICSI only resolves fertilization; embryo quality is determined by the intrinsic quality of both the egg and sperm. If egg quality is poor or sperm DNA damage is severe, embryo quality after ICSI may still be suboptimal.

Are ICSI success rates higher in Hong Kong than in mainland China?

Success rates are influenced by multiple factors, including patient age, gamete quality, and laboratory conditions. Some reproductive centers in Hong Kong have laboratory standards aligned with international norms, but their advantage primarily lies in laboratory quality control and embryology experience, not in a technological gap. Differences in success rates between individual centers may be greater than regional differences.

Does ICSI increase the risk of birth defects?

Current research indicates that the incidence of birth defects in ICSI offspring is slightly higher than in natural conception (absolute risk increase of about 1%–2%). This difference may be related to the genetic background of the parents themselves rather than being directly caused by the ICSI procedure. For male factor infertility, genetic screening should be completed before ICSI to assess the risk of passing on genetic abnormalities to offspring.

How long does an ICSI cycle take?

From initial testing to embryo transfer, a complete ICSI cycle typically takes 2–3 months. If frozen embryo transfer is chosen, the cycle may extend to 3–4 months.

ICSI Considerations by Age Group

Female Age Key Focus for ICSI Common Adjustment Strategies
Under 35 Egg quality is generally good; fertilization rate and embryo quality after ICSI are mainly influenced by sperm factors Focus on investigating sperm DNA damage and genetic factors; consider single blastocyst transfer
35–38 Egg quality begins to decline; ICSI cannot mitigate the risk to embryo quality posed by egg aging Recommend simultaneous assessment of ovarian reserve; consider PGT-A screening if necessary
Over 38 Egg quality is the primary factor limiting embryo quality; the advantage of ICSI is limited to the fertilization step Must fully inform about ICSI limitations; cumulative embryo number may be low; consider multiple egg retrieval cycles to accumulate embryos

For older women, even with ICSI, the embryo euploidy rate still declines with age. ICSI itself does not increase the embryo euploidy rate nor reduce the risk of aneuploidy.

Risk Reminder: ICSI is a mature assisted reproductive technology, but it is not suitable for all infertile individuals. The ICSI procedure carries a slight risk of mechanical damage to the egg (approximately 1%–2%) and cannot replace genetic evaluation. For cases with excessively high sperm DNA fragmentation, repeated fertilization failure in previous ICSI cycles, or明确的 genetic abnormalities, an individualized plan must be developed after a complete assessment. When choosing a reproductive center in Hong Kong, verify its license qualifications, laboratory performance data, and the experience level of the embryology team, and avoid making decisions based solely on success rate numbers.

This content is based on clinical practice in assisted reproduction and publicly available medical literature, intended for patient education and clinical reference. It does not constitute a recommendation or endorsement of any specific reproductive center. Please consult a licensed reproductive physician for specific diagnosis and treatment plans.

0 comments
Leave a Reply